Corcept Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Corcept Therapeutics is scheduled to report earnings on May 2, 2024, and the estimated EPS forecast is $0.22. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 135.41M	$ 123.60M	$ 117.72M	$ 105.65M	$ 103.06M
Gross Profit	$ 133.53M	$ 121.96M	$ 116.14M	$ 104.27M	$ 101.58M
EBIT	$ 36.81M	$ 36.38M	$ 32.93M	$ 18.43M	$ 26.06M
EBITDA	$ 28.31M	$ 36.55M	$ 33.75M	$ 19.17M	$ 26.80M
Net Income Common Stockholders	$ 30.99M	$ 31.17M	$ 27.36M	$ 31.64M	$ 56.04M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 368.22M	$ 355.23M	$ 363.26M	$ 465.06M	$ 431.67M
Total Assets	$ 621.52M	$ 594.02M	$ 524.63M	$ 617.85M	$ 577.33M
Total Debt	$ 151.00K	$ 225.00K	$ 297.00K	$ 575.00K	$ 1.14M
Net Debt	$ -368.07M	$ -355.00M	$ -362.96M	$ -464.48M	$ -430.53M
Total Liabilities	$ 114.81M	$ 132.34M	$ 103.01M	$ 88.26M	$ 583.43M
Stockholders Equity	$ 506.70M	$ 461.68M	$ 421.61M	$ 529.58M	$ 501.84M
Cash Flow	-
Free Cash Flow	$ 5.89M	$ 52.87M	$ 42.18M	$ 25.96M	$ 33.36M
Operating Cash Flow	$ 5.89M	$ 52.91M	$ 42.29M	$ 25.96M	$ 33.39M
Investing Cash Flow	$ 17.10M	$ -109.57M	$ -24.10M	$ 207.47M	$ -17.24M
Financing Cash Flow	$ 766.00K	$ -3.92M	$ -145.75M	$ 181.00K	$ -61.00K

Currency in USD

Corcept Therapeutics Earnings and Revenue History

Income Statement >

Corcept Therapeutics Debt to Assets

Balance Sheet >

Corcept Therapeutics Cash Flow

Cash Flow >

Corcept Therapeutics Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing